✦ LIBER ✦

Succinimide Hydroxamic Acids as Potent Inhibitors of Histone Deacetylase (HDAC).

✍ Scribed by Michael L. Curtin; Robert B. Garland; H. Robin Heyman; Robin R. Frey; Michael R. Michaelides; Junling Li; Lori J. Pease; Keith B. Glaser; Patrick A. Marcotte; Steven K. Davidsen

Publisher: John Wiley and Sons
Year: 2003
Weight: 135 KB
Volume: 34
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200309093

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Indole Amide Hydroxamic Acids as Potent

Indole Amide Hydroxamic Acids as Potent Inhibitors of Histone Deacetylases

✍ Yujia Dai; et al. et al. 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 62 KB 👁 1 views

Discovery of Pyrimidyl-5-hydroxamic Acid

Discovery of Pyrimidyl-5-hydroxamic Acids as New Potent Histone Deacetylase Inhibitors.

✍ Patrick Angibaud; et al. et al. 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 24 KB 👁 1 views

Sequence-specific potentiation of topois

Sequence-specific potentiation of topoisomerase II inhibitors by the histone deacetylase inhibitor suberoylanilide hydroxamic acid

✍ Douglas C. Marchion; Elona Bicaku; Adil I. Daud; Victoria Richon; Daniel M. Sull 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 469 KB

## Abstract Acetylation of histones leads to conformational changes of DNA. We have previously shown that the histone deacetylase (HDAC) inhibitor, suberoylanilide hydroxamic acid (SAHA), induced cell cycle arrest, differentiation, and apoptosis. In addition to their antitumor effects as single age

Histone deacetylase inhibitor, suberoyla

Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (Vorinostat, SAHA) profoundly inhibits the growth of human pancreatic cancer cells

✍ Takashi Kumagai; Naoki Wakimoto; Dong Yin; Sigal Gery; Norihiko Kawamata; Noriyu 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 461 KB

## Abstract Tumor suppressor genes are often silenced in human cancer; this can occur by transcriptional repression by deacetylation in the promoter regions, mediated by histone deacetylase (HDAC). HDAC inhibitors can block cancer cell growth by restoring expression of tumor suppressor genes. In th

(2-Amino-phenyl)-amides of ω-Substituted

(2-Amino-phenyl)-amides of ω-Substituted Alkanoic Acids as New Histone Deacetylase Inhibitors.

✍ Arkadii Vaisburg; et al. et al. 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 119 KB 👁 1 views

The histone deacetylase (HDAC) inhibitor

The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all-trans retinoic acid in patients with acute myeloid leukemia

✍ Andrea Kuendgen; Mathias Schmid; Richard Schlenk; Sabine Knipp; Barbara Hildebra 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB 👁 1 views

## Abstract ## BACKGROUND Valproic acid (VPA) inhibits histone deacetylase activity and, synergizing with all‐trans retinoic acid (ATRA), achieves differentiation induction of myeloid blast cells in vitro. ## METHODS We used VPA in 58 patients with acute myeloid leukemia (AML) who were too old a